Clinical Trial Update: A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004 [Phase 1]

View source ↗

Summary

A Phase 1 study update evaluating the immunologic response and virologic impact of AGS-004 in HIV patients. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AGS-004

Snippet

Sponsor: Cynthia L Gay, MD | Conditions: HIV | Phase 1 | Status: COMPLETED